These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8316859)

  • 1. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.
    Nelsen B; Tian G; Erman B; Gregoire J; Maki R; Graves B; Sen R
    Science; 1993 Jul; 261(5117):82-6. PubMed ID: 8316859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-protein-DNA complex on a B cell-specific domain of the immunoglobulin mu heavy chain gene enhancer.
    Rao E; Dang W; Tian G; Sen R
    J Biol Chem; 1997 Mar; 272(10):6722-32. PubMed ID: 9045705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Context dependent transactivation domains activate the immunoglobulin mu heavy chain gene enhancer.
    Erman B; Sen R
    EMBO J; 1996 Sep; 15(17):4665-75. PubMed ID: 8887557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETS-mediated cooperation between basic helix-loop-helix motifs of the immunoglobulin mu heavy-chain gene enhancer.
    Dang W; Sun XH; Sen R
    Mol Cell Biol; 1998 Mar; 18(3):1477-88. PubMed ID: 9488464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism.
    Andreucci A; Reeves R; McCarthy KM; Nikolajczyk BS
    Biochem Biophys Res Commun; 2002 Mar; 292(2):427-33. PubMed ID: 11906180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression.
    Libermann TA; Lenardo M; Baltimore D
    Mol Cell Biol; 1990 Jun; 10(6):3155-62. PubMed ID: 2111447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETS-core binding factor: a common composite motif in antigen receptor gene enhancers.
    Erman B; Cortes M; Nikolajczyk BS; Speck NA; Sen R
    Mol Cell Biol; 1998 Mar; 18(3):1322-30. PubMed ID: 9488447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETS protein-dependent accessibility changes at the immunoglobulin mu heavy chain enhancer.
    Nikolajczyk BS; Sanchez JA; Sen R
    Immunity; 1999 Jul; 11(1):11-20. PubMed ID: 10435575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
    Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
    Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA1 co-activates transcription in B cells through indirect association with DNA.
    McCarthy KM; McDevit D; Andreucci A; Reeves R; Nikolajczyk BS
    J Biol Chem; 2003 Oct; 278(43):42106-14. PubMed ID: 12907668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precise alignment of sites required for mu enhancer activation in B cells.
    Nikolajczyk BS; Nelsen B; Sen R
    Mol Cell Biol; 1996 Aug; 16(8):4544-54. PubMed ID: 8754855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
    Hagman J; Grosschedl R
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation by ETS and leucine zipper-containing basic helix-loop-helix proteins.
    Tian G; Erman B; Ishii H; Gangopadhyay SS; Sen R
    Mol Cell Biol; 1999 Apr; 19(4):2946-57. PubMed ID: 10082562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring functional redundancy in the immunoglobulin mu heavy-chain gene enhancer.
    Dang W; Nikolajczyk BS; Sen R
    Mol Cell Biol; 1998 Nov; 18(11):6870-8. PubMed ID: 9774700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function.
    Grant PA; Thompson CB; Pettersson S
    EMBO J; 1995 Sep; 14(18):4501-13. PubMed ID: 7556093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus.
    Carlsson R; Persson C; Leanderson T
    Mol Immunol; 2003 Jun; 39(16):1035-43. PubMed ID: 12749910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells.
    Berland R; Wortis HH
    J Immunol; 1998 Jul; 161(1):277-85. PubMed ID: 9647234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERP, a new member of the ets transcription factor/oncoprotein family: cloning, characterization, and differential expression during B-lymphocyte development.
    Lopez M; Oettgen P; Akbarali Y; Dendorfer U; Libermann TA
    Mol Cell Biol; 1994 May; 14(5):3292-309. PubMed ID: 7909357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex regulation of the immunoglobulin mu heavy-chain gene enhancer: microB, a new determinant of enhancer function.
    Nelsen B; Kadesch T; Sen R
    Mol Cell Biol; 1990 Jun; 10(6):3145-54. PubMed ID: 2111446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PU.1 as a chromatin accessibility factor for immunoglobulin genes.
    Marecki S; McCarthy KM; Nikolajczyk BS
    Mol Immunol; 2004 Jan; 40(10):723-31. PubMed ID: 14644098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.